Effect of BioStrength Training on Muscle Strength and Satisfaction in Adults Aged 30-65

NCT06727695 · tracked via the Priya Life Science Austria tracker

Sponsor

University of Graz

Phase

Not applicable

Started

2024-10-08

Last updated

2024-12-11

Condition(s) studied

Muscle StrengthBody CompositionPhysical Fitness

Investigational drug(s) / intervention(s)

BioStrength InterventionConventional training

BioStrength Intervention: Participants in the Intervention Group will undergo BioStrength training using Technogym equipment. The intervention will last for 12 weeks, with sessions conducted 3 times per week

Conventional training: Participants in the Active Comparator group will undergo a conventional strength training program using standard gym machines. Training sessions will occur 3 times per week for 12 weeks. The goal is to compare the outcomes of BioStrength training with traditional strength training.

Study summary

This study aims to evaluate the effectiveness of Technogyms BioStrength equipment compared to traditional strength training equipment over a 12-week intervention period. The study will determine whether BioStrength machines produce more effective results in terms of muscle strength and body composition. Participants will be allocated to either the BioStrength group or the traditional training group using a minimisation technique to balance important prognostic factors such as handgrip strength, age and gender between the groups. Key measurements include maximum strength tests (10RM) for leg press and chest press, handgrip strength using a dynamometer, and body composition using bioimpedance analysis. Circumference measurements will also be taken. The study will assess whether BioStrength equipment provides superior results in muscle strength, body composition and training efficiency compared to conventional gym equipment.

Eligibility

Sex

ALL

Min age

30 Years

Max age

65 Years

Healthy volunteers

Accepted

Inclusion Criteria: * • Age between 30 and 65 years * Healthy individuals without significant medical conditions * Less than 6 months of prior strength training experience * Willing and able to participate in a 12-week training program * Capable of performing strength training exercises such as leg press and chest press * Able to provide written informed consent Exclusion Criteria: * • History of coronary heart disease * History of stroke * Need for changes in antihypertensive treatment within 3 months prior to study start * Arthritis * Pregnancy or less than three months postpartum * Pain and movement restrictions * Use of medications that affect muscle strength or performance (e.g., anabolic steroids, beta-2 agonists, glucocorticoids, statins, benzodiazepines, ACE inhibitors, angiotensin-II receptor blockers, diuretics) * Any medical condition preventing participation in planned endurance and strength training

Primary outcome measure(s)

Change in Skeletal Muscle Mass — Baseline and Week 12
Skeletal muscle mass will be measured using bioimpedance analysis (BIA) at baseline and after the 12-week intervention to evaluate changes in muscle mass.
Change in Body Fat Percentage — Baseline and Week 12
Body fat percentage will be measured using bioimpedance analysis (BIA) at baseline and after the 12-week intervention to assess reductions in body fat.
Change in Handgrip Strength — Baseline and Week 12
Handgrip strength will be measured using a Jamar dynamometer, with measurements taken at baseline and after the 12-week intervention.
Change in Maximal Strength (10-RM Test) — Baseline and Week 12
Maximal strength will be measured using the 10-RM (Repetition Maximum) test for the leg press and chest press exercises at baseline and after the 12-week intervention.

Trial sites (1)

Facility	City	Region	Status
CF Leibnitz	Leibnitz, Styria	Styria	Recruiting

More University of Graz trials in Austria

Effects of Resistance Training on Patellar Tendon Properties in People With Patellar Tendinoapthy Enrolling by invitation

Muscle-tendon Pathology and Metabolic Dysregulation in CP Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06727695 on ClinicalTrials.gov ↗ ← All trials in Austria